Matthieu Tihy

13PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 27, 2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

|Jan 05, 2026
Comparison of radiological and pathological tools to assess response to neoadjuvant treatment in resected pancreatic ductal adenocarcinoma patients.

Anaïs Jenvrin, Riccardo Sartoris, Safi Dokmak

|Oct 29, 2025
Differential diagnosis and predictive markers of pancreatic neuroendocrine tumours (PanNET).

Matthieu Tihy, Agathe Hercent, Jérôme Cros

|Sep 16, 2025
Predictive value of metabolic state on PanNET response to mTOR inhibitors.

Jérôme Cros, Margot Bucau, Matthieu Tihy

|Jan 13, 2025
Temporal increase in Ki-67 index in patients with pancreatic neuroendocrine tumours.

Pauline Bourdeleau, Johanna Pokossy-Epée, Olivia Hentic

|Mar 09, 2023
Anti-CD122 antibody restores specific CD8+ T cell response in nonalcoholic steatohepatitis and prevents hepatocellular carcinoma growth.

Stéphanie Lacotte, Florence Slits, Beat Moeckli

Pageof 3

Frequent Collaborators

4 joint publications

Louis de Mestier

3 joint publications

Jérôme Cros

2 joint publications

Christian Toso

2 joint publications

Fiona M Watt